Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michaela Lang"'
Autor:
Christoph Gasche, Michaela Lang
Publikováno v:
Digestive Diseases. 33:58-67
Colorectal cancer has become one of the most prevalent malignant diseases for both men and women. Patients with inflammatory bowel diseases or certain inherited cancer syndromes are at high risk of developing colorectal cancer and have naturally the
Autor:
Werner Seeger, Axel Kretschmer, Norbert Weissmann, Johannes-Peter Stasch, Baktybek Kojonazarov, Xia Tian, Ralph T. Schermuly, Friedrich Grimminger, Anuar Kalymbetov, Hossein Ardeschir Ghofrani, Michaela Lang
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43433 (2012)
PLoS ONE
PLoS ONE
Background The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) signal-transduction pathway is impaired in many cardiovascular diseases, including pulmonary arterial hypertension (PAH). Riociguat (BAY 63–2
Autor:
Ralph T. Schermuly, Baktybek Kojonazarov, Norbert Weissmann, Werner Seeger, Johannes-Peter Stasch, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Michaela Lang
Publikováno v:
B16. EMERGING TRANSLATIONAL THERAPIES FOR PULMONARY HYPERTENSION.
Autor:
Norbert Weissmann, Michaela Lang, Baktybek Kojonazarov, Johannes-Peter Stasch, Werner Seeger, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Ralph T. Schermuly
Publikováno v:
BMC Pharmacology
The NO-sGC-cGMP signaling pathway is impaired in different cardiovascular diseases, including pulmonary hypertension (PH). Riociguat is the first of a new class of drugs, the soluble guanylate cyclase stimulators. Riociguat has a dual mode of action:
Autor:
Johannes-Peter Stasch, Friedrich Grimminger, Norbert Weissmann, Hossein Ardeschir Ghofrani, Baktybek Kojonazarov, Michaela Lang, Werner Seeger, Ralph T. Schermuly
Publikováno v:
BMC Pharmacology